U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316556) titled 'Post-Marketing Surveillance of Vliwazell(R) Prowound Dressing' on Nov. 28, 2025.
Brief Summary: This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell(R) Pro. The aim of the study is to validate the performance of Vliwazell(R) Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with ...